Embla Medical hf. (CPH:EMBLA)
29.60
-0.20 (-0.67%)
Feb 6, 2026, 11:33 AM CET
Embla Medical Market Cap
Embla Medical has a market cap or net worth of 12.73 billion as of February 6, 2026. Its market cap has decreased by -16.95% in one year.
Market Cap
12.73B
Enterprise Value
15.56B
Revenue
5.91B
Ranking
n/a
PE Ratio
24.00
Stock Price
29.60
Market Cap Chart
Since September 4, 2009, Embla Medical's market cap has increased from 2.33B to 12.73B, an increase of 447.13%. That is a compound annual growth rate of 10.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 12.73B | -8.35% |
| Dec 30, 2025 | 13.89B | -8.62% |
| Dec 30, 2024 | 15.20B | 31.74% |
| Dec 29, 2023 | 11.54B | -18.15% |
| Dec 30, 2022 | 14.10B | -21.07% |
| Dec 30, 2021 | 17.86B | -12.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.63T |
| Genmab | 129.17B |
| Coloplast | 117.87B |
| ALK-Abelló | 48.66B |
| H. Lundbeck | 37.96B |
| Zealand Pharma | 30.31B |
| Ambu A/S | 22.08B |
| GN Store Nord | 15.65B |